COVID-19 AstraZeneca Vaccination Information 

From the end of March, Albemarle Medical Practice will be receiving stock of the AstraZeneca COVID-19 Vaccine as part of Week 2, Phase 1B of the National COVID-19 Vaccine rollout.

 

To make an appointment for the AstraZeneca Vaccine, please call the practice on 9371 6000. 

We have provided some answers to Frequently Asked Questions below and will be continuously updating the website as changes and new information is released.

Frequently Asked Questions

Who is eligible to access the Astrazeneca Vaccine?


People aged 60 years and over are eligible for the AstraZeneca vaccine.

If you are aged between 18 and 59 years old and would like the AstraZeneca vaccine, please book an appointment with your GP to discuss it first.




How many doses of the vaccine do I need to have?


For the AstraZeneca vaccine, you will need to have 2 vaccines, spaced 12 weeks apart. Under current NSW Health advice, you are able to recieve your second dose after 6 or 8 weeks.




I don’t have a Medicare Card OR I’m not a regular patient of this practice.


To receive a COVID-19 at our practice you will need to have a Medicare Card Number. If you don't have one you are still eligible for a vaccine but will need to attend a GP-Led Respiratory clinic.

If you are not a regular patient of ours and you are finding the wait time too long you are able to attend the GP Respiratory Clinics.

Information of where GP Respiratory Clinics are located can be found via the Australian Governments Eligibility Criteria Checker.

If you are eligible for a COVID-19 Vaccine bookings for the Bondi Junction Respiratory Clinic can be made here




How can I prove that I've been vaccinated?


Your proof of vaccination can be accessed via Medicare online or via the Medicare app.

You can also ask us to print off a copy of your immunisation history statement.




Where can I access more information regarding the Covid-19 Vaccine?


Please head to the Department of Health Website for more information regarding the COVID-19 vaccine rollout.